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ABSTRACT 
 
The sequencing of the Drosophila genome allowed the identification of most coding 
sequences, highlighting the necessity for a functional assignation of the identified genes.  
The information extracted from the sequence directly classified a considerable fraction 
of genes into known molecular categories, although there is still a large proportion of 
them that, due to poor sequence conservation, are not included into any informative 
class.  Furthermore, in many instances the molecular nature of a protein is not 
particularly revealing about its functional requirements and network of interactions.  In 
this manner, complementary genomic approaches to gene identification by sequence 
conservation are fundamental both in Drosophila and other organisms to assign 
particular functions to annotated genes. The approach more successful in the 
Drosophila field is the undertaking of genetic screenings to identify sets of interacting 
genes and genes controlling particular cellular processes.  Classic genetic screens 
comprise all those based on a “phenotypic” paradigm, where the generation of large 
collections of mutant chromosomes is followed by their mapping.  This approach has 
been recently expanded to include “genomic” tools, such as the use of microarrays and 
interference RNA, as well as reverse-genetics techniques, seeding the way to a 
“functional” annotation of the Drosophila genome.  
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INTRODUCTION 
 
For almost a century, Drosophila has been a favourite creature in genetic 
research, and the knowledge of the fundamental principles of genetic organization in 
eukaryotic organisms stems from the early work carried out by the school of Thomas 
Hunt Morgan during the early years of the XX century (1).  The success of the fruit fly 
in relation to other model organisms is due in part to several characteristics of 
Drosophila, including relatively short generation time, large number of progeny and 
low genome complexity.  These features, combined to the rich adult and embryonic 
morphologies, complex physiology, stereotyped behaviour, and the variety of ecological 
adaptations of Drosophilids, have contributed to expand the use of Drosophila from 
basic genetic research, mostly gene organization and transmission, to the analysis of the 
mechanistic basis of Development and Genome evolution.  Furthermore, the 
conservation in the coding sequences between Drosophila and other organisms, 
including humans, has trigger an enormous expansion in the application of flies into 
basic biomedical research.  Apart from the intrinsic characteristics of the Drosophila 
biology, other important aspects necessary to understand the success and power of 
Drosophila as a model organism are the traditions of sharing genetic strains and 
information among the fly community, as well as the effort of many individuals to 
systematize and make accessible in a comprehensive manner the wealth of information 
available to Drosophila researches.  In this manner, of paramount importance to the 
Drosophila community today are the databases generated by the Flybase Consortium, 
Flymine and the Berkley Drosophila Genome Project (see Table 1).  Flybase is a 
database of genetic, molecular and bibliographic data for Drosophila, whereas the 
related BDGP aims to finish the sequence of the Drosophila genome and to maintain 
biological annotations of this sequence.  Additional information and reposition of 
research materials, including fly strains, cell lines, cDNA clones and antibodies exists in 
several databases funded by public grants (see Table 1 for a summary).  With the help 
from these initiatives, Drosophila has become today a versatile and practical model 
organism with applications in many fields of Biological research. 
 
The primary reason to choose Drosophila for the study of almost any aspect of 
eukaryotic biology is still the immense possibilities offered by the sophisticated genetic 
techniques available.  Thus, not only a wealth of genetic information already exists for a 
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large fraction of the Drosophila genome, but also several methods are at hand to 
generate mutations in genes of interest, to identify genes on the basis of genetic 
interactions and to construct transgenic flies for studies of gene regulation and function.  
Moreover, the sequencing and annotation of the Drosophila genome has opened the 
door for the application of high-throughput techniques, leading to the determination of 
gene expression profiles during development and in a variety of experimental 
conditions, and to construct a preliminary global map of protein-protein interactions.  
High throughput approaches allow extending the range, speed and type of genetic 
screens, from whole-organism screens to others based on cell-cultures.  Sequence 
information and genome annotation also permits the development of reverse-genetics 
techniques, mainly through the use of interference RNA, Tilling techniques, and, to a 
lesser extent, gene targeting by homologous recombination.  In this manner, studies in 
Drosophila are providing key insights into related processes occurring in other species, 
such as embryonic development, neural organization, growth and tissue morphogenesis, 
as well as helping to clarify the function of genes involved in genetic diseases in 
humans.  Certainly, it appears that the goal of determining how the approximately 
14.000 Drosophila genes generate a functional multicellular organism is within reach in 
the next decades. 
 
 
Name Web Site Description 
   
FlyBase http://flybase.org Drosophila Genetic and molecular data   
FlyMine http://www.flymine.org/ Drosophila and Anopheles genomics 
Berkeley Drosophila Genome Project http://www.fruitfly.org/ Drosophila genome anotation 
Drosophila Genomics Resource Center http://dgrc.cgb.indiana.edu/ cDNA clones, cells lines, vectors and microarrays 
Homophila http://superfly.ucsd.edu/homophila/ Drosophila genes related to human genetic deseases 
Bloomington Drosophila Stock Center http://flystocks.bio.indiana.edu/bloomhome.html Drosophila Stock Center 
Harvard Drosophila Stock Collection http://drosophila.med.harvard.edu/ Exelixis collection of Drosophila stocks 
DrosDel Project http://www.drosdel.org.uk/ Isogenic deficiency kit for Drosophila melanogaster  
Japanese National Institute of Genetics http://www.shigen.nig.ac.jp/fly/nigfly/ Stock center from the NIG, Japan 
BDGP/Baylor Gene Disruption Project http://flypush.imgen.bcm.tmc.edu/pscreen/ Gateway to the Gene Disruption Project 
FlyView http://flyview.uni-muenster.de/html/About.html Gene expression patterns  
Drosophila Heterocromatin Project http://www.dhgp.org/index.html Drosophila heterochromatin gene project 
Drosophila RNAi Screening Center http://flyrnai.org/RNAi_index.html High throughput RNAi screens 
Developmental Studies Hybridoma Bank http://www.uiowa.edu/~dshbwww/ Storage and distribution of monoclonal antibodies 
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TABLE 1 
Summary of Drosophila resources available on the WWW.  For a complete list see Flybase 
(http://flybase.org/allied-data/resources.html). 
 
 
In this review, we will summarize the different methods used in the Drosophila 
field, and their applications to the identification and characterisation of genes 
contributing to a variety of biological processes.  We will include the use and recent 
modifications of conventional loss-of-function screens, the contribution and 
applications of transposable elements, and the recent impact of post-genomic 
technologies, such as the identification of expression profiles using microarray 
techniques and genetic screens based in interference RNA in cultured cells.   
 
 
1. - THE TRADITION OF DROSOPHILA AS A MODEL ORGANISM FOR 
GENETIC STUDIES 
 
The first reason for the success of Drosophila as an experimental organism was 
the high frequency with which mutants flies turned up in breeding experiments carried 
out in the Morgan laboratory in the early 1910.  This was mainly a consequence of the 
scaling up in the number of cultures maintained in the laboratory, in a process described 
as autocatalytic: “the more crosses were done, the more mutants turned up” (2).  By the 
late 1910 the number of mutants available, and the development of conceptual 
approaches to use them in neo-mendelian experiments, leaded to the construction of the 
first genetic maps, using the frequency of meiotic recombination as a measure of 
physical distances between mutants (1).  Early Drosophila workers from the Morgan 
group were mainly concerned with genetic transmission and mapping, and in many 
ways their work established most of the parameters, principles and techniques used 
today in Drosophila genetics.  In the nine decades of Drosophila use in the laboratory 
since then, novel applications and technical advances have moved hand by hand, 
speeding the conversion of Drosophila from a pure genetic workhorse to a versatile 
 7 
model in developmental and cellular biology.  The technical advances include the use of 
ionizing radiation and chemical agents to induce mutants, the identification and 
posterior domestication of transposable elements, the development of transformation 
techniques using P-elements, DNA cloning by genomic walk, the construction of cDNA 
libraries, the adoption of methods to study in situ gene expression, the use of techniques 
to construct mosaic animals and the design of direct ways to modify gene expression in 
the organism.  The availability of these techniques, combined with the detailed 
histological description of embryonic and imaginal development immensely promoted 
the use of Drosophila in Developmental Biology studies.  In this way, the technical 
achievements and the understanding of the basic rules governing Drosophila 
development set the perfect stage to use the information provided by the sequence, 
accelerating even more the rate of discovery in new areas of Biology important not only 
for the fly, but also for general biology and biomedicine. 
 
 
2. - THE DROSOPHILA GENOME 
 
The sequencing of the Drosophila genome was the result of the collaboration 
between the Berkeley Drosophila Genome Project (BDGP), led by Gerry Rubin, and 
the genomics company Celera.  The method to sequence the genome followed by the 
BDGP and the related European Drosophila Genome Project (EDGP) was a ‘clone-by-
clone’ strategy, using the genome coverage generated in Cosmid, YAC, P1 and BAC 
clones.  This approach resulted in sequencing approximately the 20% of the 
euchromatic DNA by 1999.  These projects were greatly accelerated in 1998, when 
Celera applied its ‘shotgun’ sequencing strategy to Drosophila.  In brief, shotgun 
sequencing relies on breaking the DNA into random pieces that are sequenced and 
assembled by computational methods.  The combined approaches of the public 
consortiums and Celera resulted in the publication of what was named “Release 1” of 
the annotated sequence by 2000 (3).  Gene annotation relied mainly in gene-prediction 
programs, and was helped by the BDGP sequence data of full-length cDNAs and 
expressed-sequence tags (ESTs).  Since the first release of the sequence, the annotation 
has been improved by the use of additional functional and comparative data, and by 
large-scale sequencing of cDNAs, resulting in the public availability of subsequent 
Releases, from 1 to 5 by August 2006 (4).   
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 Sequence information is extremely useful on its own, because it speeds up 
research in the field and broads the range of experimental approaches available for 
researches.  Additionally, the annotation of the genome acquires particular relevance 
when the information content is compared among different species.  This applies to 
species belonging to the same family, the Drosophilids, and to species philogenetically 
distant, such as C. elegans and A. gambiae (5).  Comparing related species helps in 
many ways to genome annotation, allows the identification of conserved regions beyond 
the protein-coding DNA, and leads to the analysis of evolutionary rates.  The 
sequencing of the Drosophila melanogaster genome was followed by a coordinated 
project to sequence several other Drosophilids.  So far, ten different Drosophila species 
have been sequenced, and it is expected that the core manuscripts describing the basic 
assemblies, annotation sets and overall comparative descriptions will be submitted by 
September 2006 (see Flybase).  A comparative analysis of the predicted proteins from 
the genomes of Drosophila melanogaster, C. elegans, and S. cerevisiae undertaken in 
the context of cellular and developmental processes, showed that the non-redundant 
protein sets of flies and worms are similar in size and are only twice than that of yeast 
(5).  This analysis assigned 7419 fly proteins to either protein families or domain 
families.  Furthermore, about half of the fly protein sequences show similarity to 
mammalian proteins.  In the context of the uses of Drosophila as a model system for 
biological research, several conclusions are particularly revealing.  First, it was noted 
that approximately 47% of Drosophila coding units have single orthologs counterparts 
in other species (6).  This number increases to 85% when only genes with defined roles 
in development are considered, suggesting that these functions are ancient and under 
considerable evolutive constrain (6).  The degree of genomic conservation is even more 
impressive in the case of signalling pathways.  For example, almost all members of the 
decapentaplegic signalling pathway (Dpp is member of the BMP/TGFβ superfamily of 
ligands) are represented by individual orthologs genes in Anopheles, and only the 
negative regulator brinker and the ligand screw from Drosophila appear to be absent in 
Anopheles (6).  A second large category of close similarity includes a total of 579 
orthologs restricted to Anopheles and Drosophila.  These genes do not share domains 
with genes in other organisms, and they likely determine insect-specific characters, such 
as odour and taste reception, cuticle formation, and insect-specific defence mechanisms.  
Interestingly, only about 100 of these have been functionally characterise
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Drosophila, suggesting that mutants in the insect-specific set of genes cause either very 
subtle phenotypes, affect traits under the control of multiple redundant inputs, or are 
involved in processes unlikely to cause easily-scored phenotypes.  Perhaps not very 
surprisingly, only a handful of the genes unique to Drosophila (84 of 2570) have 
functional annotations mapped to Gene Ontology (GO) terms (6).  In this manner the 
class of genes predicted from the sequence includes the larger fraction of 
uncharacterized genes.  It has been argued that ‘predicted’ genes have a higher rate of 
protein evolution than genes selected for experimental study on the bases of mutant 
phenotypes (6, 7). 
 
 Of great importance is the fact that sequence searches using 289 human genetic 
diseases genes show that 61% have orthologs in Drosophila, favouring the use of the 
available genetic techniques of the fly in biomedical research (6, 8).  Furthermore, there 
is a large correspondence of Drosophila proteins and their human counterparts 
considering those involved in the regulation of gene expression, cell signalling 
pathways, basic cell biology processes such as cell adhesion and migration, cell cycle 
and cell death, cytosqueleton dynamics, protein transport across cell membranes, as well 
as DNA, RNA and bioenergetic metabolisms, reinforcing the validity of the fly as a 
convenient experimental model for basic research (6).  Finally, gene duplication affects 
only a very small fraction of Drosophila genes, and in most cases Drosophila contains 
single representatives of genes forming complex families in humans (3).  This has the 
advantage of reducing the possibility of functional redundancy between orthologues, 
facilitating the characterization of gene functions.  The availability of the Drosophila 
genome has deeply affected the way experiments are conducted in the field, stimulating 
the development of new technologies.  First, sequence information saves time with 
regard to the mapping of mutations and cloning of genes, guiding and speeding 
conventional genetic analyses.  As a consequence, the number of genetic screens carried 
out in flies has increased in the last years, from 8 published papers in 1999 to 22 in 2005 
(authors search in PubMed).  Second, the identification of all transcriptional units 
allows the development of new functional genomics approaches, such as the 
construction of complete Drosophila microarrays and interference RNA libraries.  
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3. - GENE SEARCH IN DROSOPHILA 
 
The functional analysis of any gene mainly consists in the meticulous study of 
the consequences of its loss on the morphology, physiology or behaviour of the animal.  
The entry point for these studies is a mutation affecting a particular tract of interest.  
Searches for mutations are carried out by “genetic screens”, involving the isolation and 
phenotypic classification of a large number of mutants, their mapping to chromosomal 
regions and, ideally, to the affected genes.  In the best of cases this approach provides a 
powerful mean to analyze complex biological processes, and relies in the ability to 
manipulate the genome to obtain mutations.  In general genetic screens are restricted to 
either loss-of-function alleles, generated by chemical mutagenesis, or, alternatively, to 
gain-of-function alleles, through the application of the GAL4/UAS system (9, 10).  
Complementary to conventional “phenotypic screens”, large-scale gene searches also 
use the criterion that the domain of gene expression is indicative of specific functional 
requirements.  The object of the experiment is to identify sets of genes with similar 
temporal or spatial expression patterns.  In either case, these approaches do not 
necessarily require prior knowledge of the genome, although they are much more 
efficient when the sequence information is available.  In what follows, we will discuss 
the more frequent applications of Drosophila genetics, from forward genetic screens to 
the more recent development of reverse genetics techniques. 
 
3.1 Gene identification through mutagenesis screens 
 
The variety of genetic methods developed to identify genes and to link them to 
their biological functions have in common their dependence on the ability to detect 
phenotypes and the subsequent mapping of mutations to single genes.  These 
approaches have the limitation of being time-consuming, particularly when chemical 
mutagenic agents are employed.  The main advance in this area have been the extension 
of the phenotypic traits scored, from altered external morphologies to a wide range of 
biological aspects, including internal tissues by using tissue-specific reporters and 
methods of generating mosaics, fly behaviour and immunity.  
 
3.1.1 Loss of function screens 
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Since the more reliable information about the function of a gene is the phenotype of its 
absence, it is not surprising that a large proportion of genetic screens aim to identify 
loss-of-function mutations.  The requisite for these experiments to be successful are: 1) 
to select a trait easy to score, 2) to design a clever protocol of crosses, including the 
establishment of stable stocks, that minimize fly handling, 3) to construct isogenic 
chromosomes to facilitate the posterior mapping of the mutants and 4) to scale up the 
screen to reach genome saturation.  Loss-of-function screens generally involve the 
generation of a large collection of randomly induced mutations in balanced stocks.  This 
step is the most time-consuming and a burden for the laboratory resources, and 
therefore the screening of the stocks for the desirable phenotypes must be done 
simultaneously to the initiation of the novel mutant stocks.  The end result of this 
approach is a collection of mutations induced on the same genetic background that 
display a phenotype in the tissue of interest.  In the more favourable cases, the grouping 
of the mutants in phenotypic classes allows the dissection of the process under study 
into a number of genetic steps, and the classification of the genes into sets with similar 
requirements.  This information is extremely useful about the way genes interact to 
control a particular biological process, and it does not require prior knowledge about 
their identity or molecular nature. 
 
The screens conducted in the late 1970s and 80s to identify genes affecting 
embryonic development exemplified this approach (11, 12).  This work aimed to 
identify mutations in genes controlling embryonic segmentation by screening for 
phenotypes in the embryo cuticle.  The cuticle is secreted by the epidermis, and contains 
patterned elements arranged in a segment-specific manner.  Because each cell secretes 
cuticle depending of its position in the segment, cuticle differentiation and cell identity 
are directly related, and the screens isolated a large fraction of the genes involved in 
generating positional information in the embryo.  For example, many of the genes 
subsequently classified as members of the Hedgehog, Dpp/BMP, Notch and Wnt 
signalling pathways were identified in these screenings, as well as a large number of 
transcription factors involved in the subdivision of the epidermis into segments and in 
smaller regions within segments (13).  The grouping of the mutants into coherent 
phenotypic classes such as “gap”, “pair-rule” and “segment polarity” also allowed, 
before the molecular nature of the affected genes was identified, to establish the 
mechanistic basis of segmentation (11).  These screens used EMS as a mutagen, and 
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were optimized to identify genes required in the zygote with no maternal contribution.  
Subsequent screens were designed to identify maternal-effect mutations, resulting in the 
identification of the genes that establish the dorsal-ventral and anterior-posterior axes 
during oogenesis (14-16).   The characterization of the genes identified in these screens 
took almost a decade for a large fraction of the ever-growing Drosophila research 
community.   
 
Other loss-of-function screens used collections of P-element insertions, 
chromosomal deficiencies or newly induced sets of mutants, and were focussed to 
dissect processes as diverse as gravitaxis (17), synaptic transmission (18) and 
synaptogenesis (19), the auditory response (20), dendritic morphogenesis (21, 22), 
larval optic lobe development (23), behavioural response to touch (24), muscle 
development (25), meiosis (26), DNA replication (27), heart function (28) and 
metastasis (29). 
 
3.1.2 Loss of function screens in adult structures 
 
The adult fly was the main phenotypic realm for Drosophila researches up until 
the embryo took a more prominent place in the 1980s.  However, early work was 
engaged either with spontaneous mutations arising from natural populations or with the 
isolation of novel alleles either in known genes or in particular chromosomal regions (7, 
30, 31).  The handicap of screens for adult characters is the recessive lethality of most 
mutations affecting genes with basic cellular and developmental roles.  Some early 
efforts to identify genes involved in adult development coupled mutagenesis to clonal 
analysis, to look for cell markers in the adult cuticle (32).  However, before adult 
screens could be carried out efficiently, it was necessary to develop methods to induce 
mosaics of treated chromosomes with high efficiency.  Such methods were only 
available after the adoption of the yeast system of recombination, based on the site-
specific recombination induced in FRT sites by the enzyme FLP recombinase (33).  
Site-specific recombination was used to make treated chromosomal arms homozygous, 
but only in clones of cells that were screened for a phenotype.  The expression of the 
FLP enzyme can be driven either by a heat-shock promoter, or more efficiently, by 
directing its expression in a particular tissue of interest, using a combination of a tissue-
specific Gal4 line and FLP cloned under control of UAS sequences (34).  These screens 
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involve only one generation (F1) of flies, and by using the appropriate crosses permit to 
construct healthy flies heterozygous for newly induced mutants, but formed by 
homozygous cells in the tissue of interest (35).  Screens in mosaic animals have been 
carried out to identify genes required for the adhesion between the dorsal and ventral 
wing surfaces (36), tumour suppressors (37), synaptic transmission mutants (18), axon 
guidance in the eye (38) and cell migration defects (39), among others. 
 
3.1.3 Gain-of-function screens 
 
Since it is estimated that two-thirds of Drosophila genes are not required for 
viability (40), a large fraction of the genome is not accessible to conventional loss-of-
function screens.  An alternative gene identification method relies on the phenotypic 
consequences of the ectopic and/or increased expression of genes in a particular tissue 
of interest.  It has been observed that this manipulation of gene expression results in 
phenotypes that are informative about the normal function of the gene.  For example, 
during vein formation the ectopic expression of dominant-negative forms of proteins 
belonging to the Dpp, Notch and EGFR pathways results in phenotypes very similar to 
those of the corresponding loss-of-function alleles, whereas ectopic expression of 
activated forms of the same genes cause opposite phenotypes (41).  In addition, the 
gain-of-function approach has the potential to uncover genes that, due to functional 
redundancy, are not easily found in loss-of-function screens.   
 
To allow systematic miss-expression screens in Drosophila, Rørth (1996) 
developed a modular system combining P-element insertional mutagenesis with GAL4 
regulated gene expression (9).  The system is designed to allow conditional expression 
of genes that are randomly tagged by the insertion of a P-element (10).  The P-element 
carries GAL4 binding sites (UAS sequences) and a basal promoter oriented to direct 
expression of genomic sequences adjacent to the P-element insertion site (Fig. 1).  
When combined with a source of GAL4, the P-element directs expression of any gene 
that lie next to its insertion site.  The basis of identifying genes by the consequences of 
their over-expression is that mutant phenotypes result from the expression of a gene in a 
place where it is not normally present (ectopic expression) and/or by its expression at 
higher than normal levels (gain-of-expression).  However, the main limitation of over-
expression screens is that P elements insert non-random, but with some sites being 
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highly preferred (hot-spots) and others very rarely targeted by the P element (cold spots) 
(50).  The P-element bias implies that only a fraction of genes will be targeted with a 
reasonable frequency to allow their identification.  The second restriction of over-
expression screens is related to the uncertainty about unspecific effects caused by 
ectopic gene expression on a particular developmental system.  In general, gain-of-
function screens using P-UAS elements consist in the analysis of the phenotypes 
resulting from the combination of a previously established collection of mapped P-UAS 
strains and a Gal4 line expressed in the tissue of interest.  Alternatively, large numbers 
of P-UAS lines can be generated by transposition, and crossed to a Gal4 line of interest 
to select and map only those P-UAS which in combination with the Gal4 result in a 
mutant phenotype (51).  The use of different P-UAS constructs suitable for gene 
targeting (42, 52), and the construction of Gal4 lines expressed in restricted patterns, 
has allowed the undertaking of gain-of-function screens directed to identify genes 
affecting, among others, imaginal development (52), sensory organ formation (53), 
thorax formation (54), synaptogenesis and motor axon guidance (55), the development 
of the central nervous system (56), wing and eye disc growth and development (57, 58), 
vein patterning (51), male germ-line stem cell maintenance (59), muscle patterning (60), 
and the formation of the antennal lobes (61). 
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FIGURE 1 
Summary of P-element based vectors commonly used in Drosophila genetics.  P-EP 
(10), P-GS (42), P-Gal4 (9), P-lacZ (43, 44), Gene targeting vectors (45), XP, (46), RS 
(47), UAS (9), Hs (48) and Protein trap (49).   
 
 
3.1.4 Searching for modifiers: loss and gain of function screens in sensitized 
genotypes 
 
All of the above mentioned genetic screens were carried out in wild-type genetic 
backgrounds.  Additionally, screens can be conducted in particular mutant backgrounds 
of interest, named “sensitized background”.  In these cases, the screen aims to identify 
genes belonging to pre-determined sets of interacting genes, such as elements of a 
signalling pathway or a transcriptional network.  The rationale for these screens was 
defined in a seminal paper in which regulatory genes of the bithorax and achaete-scute 
gene complexes were identified (62).  In modifying screens, it is expected that the 
background genotype restricts and determines the set of mutants susceptible to be 
identified.  The underlying idea is that the gene-dose of elements belonging to a given 
pathway became critical for the phenotypic outcome after particular perturbations in the 
 16 
pathway.  When this happens, mutants that in heterozygosis don’t show a phenotype are 
able to increase (“enhancers”) or reduce (“suppressors”) the phenotype of a particular 
genetic condition.  This allows conducting the experiment in one generation, facilitating 
the screening of large numbers of treated chromosomes.  In general, all screens of the 
modifier type consist in crossing into a defined genetic background, chromosomal 
deficiencies, P-UAS elements or newly induced mutants.   
 
There are many examples of successful screens aiming to identify members of 
known signalling pathways, such as those targeting the Sevenless and Epidermal growth 
factor receptor (63-70), Notch (71-75), Ecdysone (76), Dpp (77-79), JAK/STAT (80, 
81), Hedgehog (82, 83), TNF (84) and wingless (85-88) pathways.  Similar screens have 
also been conducted to isolate interactors of different transcription factors, such as 
Deformed (89-91), Seven in absentia (92), Cut (93), fushi tarazu (94), Kruppel (95, 96) 
and Brahma (97), as well as cell-survival factors (98), tumour suppressor proteins (99), 
cell-cycle regulators (100-104), and interactors of non-muscle myosin-II (105) and 
Presenilin (106) 
 
An important advantage of modifiers screenings is that they can be easily 
adapted to searchers for mutants affecting the phenotype caused by the miss-expression 
of engineered proteins (107), including non-Drosophila proteins (108).  This has 
allowed the design of modifier screens in a Drosophila model of tauopathy (109) and 
other neurodegenerative diseases (110-112), as well as other human genetic diseases 
such as Multiple Endocrine Neoplasia Type 2 (113), cardiomyopathies (114) and 
Adenomatous Polyposis Coli (APC)(115), among others.    
 
 
3.1.5 Public resources for loss- and gain-of-function searches 
 
Most screens are carried out by individual groups, which in some cases generate the 
collection of mutants or P-element lines to be searched for either specific phenotypes or 
interacting genes.  However, a number of resources are already available to conduct 
these experiments with established public collections of P-elements or genetic deletions 
(Table 1).  In this manner, any screen can be carried out without the necessity of first 
generating novel variants.  Some of the resources for gene mapping and modifying 
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screens are the collection of large chromosomal deletions with a genome-wide coverage 
maintained by the Bloomington stock center and the high-resolution and molecularly-
mapped deficiencies deleting only few genes per fly strain from the DrosDel Project 
(47) and the Exelexis collection (116).  Similarly, a BDGP project is in progress to 
target all the Drosophila genome with P-elements, which currently includes about 70% 
of the annotated genes (117, 118).  Even if not all insertions result in a loss of function, 
because P-elements are generally located in introns or other non-coding regions, the use 
of imprecise excision should made possible to generate loss-of-function alleles in any 
gene targeted by a P element.  Additional resources, such as large collections of P-UAS 
inserts are available at the Bloomington stock center and National Genetics Institute in 
Japan (10, 42).  Finally, a large-scale effort is in progress to generate transgene-
mediated RNAi for the complete Drosophila gene content 
(http://www.shigen.nig.ac.jp/fly/nigfly/).  Such lines could be used to obtain loss-of-
function conditions in genes not amenable to conventional mutagenesis, as well as 
facilitate genome-wide screens. 
 
3.2. - Genetic identification through expression pattern analysis 
 
Cell-fate changes that occur during development are usually accompanied by changes in 
gene expression.  Thus, exhaustive knowledge of the spatial and temporal gene 
expression patterns is necessary to understand the regulatory networks directing 
development (119).  Large-scale searches for genes based in expression patterns were 
first conducted using engineered P-elements carrying a reporter gene and a basal 
promoter (Fig. 1).   
 
The more widely reporters are the lacZ gene and, more recently, GFP, which 
allows visualization of gene expression in living animals.  Screens aiming to identify 
expression patterns are named “enhancer trap” screens, because in these cases the target 
of the screen is genomic DNA able to direct in restricted spatial patterns the expression 
of the reporter (43, 120, 121).  Recent adaptations of enhancer trap screenings to adult 
territories include the “yellow+” and “GFP” methods, where the mobilised P-element 
encodes GAL4 (122, 123).  In the yellow+ method, the Gal4 protein directs the 
expression of a yellow transgene, which rescues the pigmentation defect caused by the 
yellow mutation only in specific subsets of the adult pattern (122).  Enhancer trap 
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screens revealed the enormous richness of regulatory information contained in the 
genome, and contributed to the identification of many genes with restricted expression 
patterns to particular tissues.  A repository of gene expression patterns during 
embryogenesis documented with extensive digital images, controlled vocabulary 
annotations and microarray profiles, is been generated by the BDGP, aiming to 
determine systematically the expression of all annotated genes using in situ 
hybridization (124).  The generation of modified P-elements with splicing sites flanking 
the coding region of GFP (Fig. 1) permits coupling the determination of the expression 
pattern with the identification of the protein sub-cellular localization.  This gene-
targeting technique might prove extremely powerful when applied in sufficient large 
scale to identify the cellular compartments where the proteins are localised, as well as to 
study changes in subcellular distribution of proteins under different experimental 
conditions.    
 
4. - Genetic identification using high-throughput techniques 
 
Genetic screens in all their many formats continue to be a very active field of research 
in the Drosophila model, and the complete sequencing of the genome certainly has 
reinforced this approach.  In addition, the availability of a high-quality genomic 
annotation makes possible the application of other high-throughput techniques, which 
have been quickly adopted by the fly community.  In particular, two aspects that we will 
consider are microarray techniques and the use of interference RNA-based screens 
carried out in cell cultures.  
  
4.1 The use of microarrays in gene search 
 
Before the development of microarrays for Drosophila, the only way to identify large 
sets of genes expressed in a tissue of interest was to use laborious techniques of 
subtractive hybridization.  This approach was used to identify genes that are expressed 
at the beginning of gastrulation (125), mesoderm (126, 127), and in purified follicle 
cells (128).  The complete sequencing of the genome and the development of 
microarrays have enabled global gene expression analysis, which combined with cell 
sorting and genetic manipulations has immense power to analyse gene networks.  
Microarrays rely on the hybridisation of a labelled sample, prepared from mRNA 
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extracted from the tissues of interest, to nucleic acids fixed to a slide, and allow 
thousands of hybridisation assays in one experiment (129).  The reactions can be 
competitive, where the relative hybridisation of two samples labelled with different 
fluorescent molecules is measured, or non-competitive reactions with a single labelled 
sample.  Currently, Drosophila researchers use three main array platforms; spotted 
cDNA amplicons, genomic amplicons and oligonucleotides.  cDNA arrays are limited 
by the coverage of the available cDNA collections, where oligonucleotides and genomic 
amplicon arrays rely mostly on genome annotations, being capable of a complete 
coverage of transcripts (see (129) for a comprehensible review). 
 
Microarray studies are being used in Drosophila to analyse many complex 
biological processes that can be grouped into several categories including cell- or organ-
type expression profiling, transcriptional responses to environmental challenges, the 
analysis of gene expression during developmental transitions, the identification of genes 
affecting particular molecular processes, and the detection of changes in gene 
expression caused by genetic manipulations.  In this last case, the object of the 
experiment is to compare the wild type versus a mutant or versus the over-expression of 
a gene of interest using the Gal4/UAS system.  Microarray studies can be conducted on 
whole organisms, on particular tissues easy to dissect or even on GFP-labelled cells 
isolated using automated cell sorters.  In addition, they can also be applied to cell 
cultures, allowing the description of global expression patterns in cells treated with 
particular interference RNAs (see below).  A bibliographic search in PubMed using the 
terms “microarray” and “Drosophila” reveals the extent and scope that microarray-
based approaches are having in the field.  Thus, cell-type expression profiling has been 
carried out in migrating cells during oogenesis (130), germ stem cells (131, 132), 
miogenesis (133, 134), Malpighian tubules (135, 136), glial cells (137), neural midline 
cells (138), wing disc and pupal cells (139-141), and larval haemocytes (142).  
Similarly, the number of developmental processes analysed by expression profiling 
comprises circadian rhythms (143-145), transdetermination in imaginal discs (146), 
aging (147-150), cellularisation (151), gastrulation (152), mating (153), metamorphosis 
(154, 155), dorso-ventral patterning in the embryo (156), segment identity (157), sex-
specific expression (158) and different aspects of the immune defense (159-163). 
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The analysis of molecular processes using microarrays includes the 
identification of microRNA targets (164), non sense-mediated mRNA decay (165), 
splicing (166, 167) and DNA replication (168).  The transcriptional responses to 
environmental challenges is another favourite field of research and includes the study of 
heat-shock induced transcripts (169-171), response to cold hardening treatment (172), 
dietary changes (173-176), genetic and environmental stress (177, 178), ionizing 
radiation (179), sleep-deprived and sleeping flies (180), defence responses to toxins 
(181, 182) or to other chemicals such as Methotrexate (183) and DDT (184-186).  The 
area more promising includes the identification of changes in gene expression caused by 
genetic manipulations.  So far, microarrays have been applied to polyglutamine toxicity 
(187), mutants with acute or chronic alterations in neuronal activity (188), response to 
hypercontraction-induced myopathy (189), identification of targets of of the 
transcription factors Eyeless (190), Ultrabithorax (191), Retinoblastoma factor (192), 
dFOXO (193), the male-specific lethal complex (194). }, dMyc (195), transcriptional 
repressor complexes containing Histone deacetylases (196), activating transcription 
factor-2 (197), Hrp59 (198), the trithorax protein Ash2 (199), proneural proteins (200) 
and dMed6 (201).  Other experiments aim to identify posttranscriptional regulation by 
Pumilio (202, Ras-induced overproliferation in the hemocytes {Asha, 2003 #443), 
EGFR (203), TGFβ (204), JNK or AP-1 dependent transcription in neurons (205), 
guanylyl cyclase targets (206). the tumor supresor brat (207) and steroid hormone 
targets (208). Finally, microarrays are increasingly been used for evolution and 
population genetics studies (209-212).  
 
Microarrays generate awesome datasets that are a serious challenge to analyse.  
In general, the microarray experiment is followed by the annotation of the identified 
genes using GO standards, and because only in a small fraction of cases their function is 
known, the challenge is to determine them using conventional genetics or interference 
RNA approaches.  Excellent examples of this approach are the analysis of myogenesis 
by transcriptional profiling, in situ hybridization and functional studies of selected 
candidates (133), and the study of the transcriptional network downstream of the Dorsal 
transcription factor, combining microarray assays, in situ hybridization and 
bioinformatics methods (156). 
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4.2. - Genetic screens in cell cultures using reporters and RNAi techniques 
 
Drosophila cells in culture take up double-strand RNA (dsRNA) using bathing 
protocols, and in general a 72 hours treatment cause a specific and dramatic depletion of 
the targeted gene product (213, 214).  The sources of dsRNAs are long RNA molecules, 
which are processed in the cell into small interference-RNA without the necessity of 
expensive production by chemical synthesis.  The long dsRNA can be synthesized from 
PCR products obtained either from existing cDNA collections or from genomic DNA, 
followed by an in vitro transcription reaction with RNA polymerases.  Experiments 
using dsRNA involve the design and synthesis of a dsRNA library, the incubation of 
cells with the dsRNAs and the detection of fluorescent signals revealing the expression 
of a reporter or a cellular antigen.  The screens conducted in cells allow the detection of 
cell phenotypes not easily scorable in the organism, such as cell lethal factors or 
specialized gene functions monitored through the use of reporter-based assays.  
 
The use of dsRNA makes feasible the analysis of gene families, by looking for 
the phenotypes of all genes, either singly or in combination, that contain a common 
protein domain.  This approach was used to study the involvement of kinases and 
phosphatases in the Hedgehog signalling pathway (215), and the function of histone 
deacetylase proteins (196).  dsRNA screens have also be applied to the entire genome, 
searching for novel components of known signalling pathways, such as Wingless (216), 
JAK/Stat (217), TNF (218) and Hedgehog (215, 219).  In addition, other published 
screens aimed to identify genes affecting a variety of cellular processes, including cell 
morphology (220), cytokinesis (221), cell proliferation (222), the response to 
micobacterial infection (223), and components of innate immunity (224).  
 
 The strengths of dsRNA screens are their versatility, based in the diversity of 
cell lines available and functional assay designs, and their speed, because the 
experiment can be coupled to automated detection and acquisition of images.  The 
possibility of undertaking the experiments in specialized centres offering dsRNA 
facilities, such as the Drosophila RNAi Screening Center at Harvard Medical School 
(http://flyrnai.org/RNAi_index.html), will certainly contribute to make the technique 
available to small laboratories.  In some cases, it might still be required to use dsRNA in 
vivo on a large scale.  Large-scale experiments using dsRNA have been conducted in 
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Drosophila embryos (225), although the necessity of injection by hand limits the 
applicability of this approach.  However, the generation of a repository of RNA 
interference strains with a genome-wide coverage at the National Institute of Genetics 
(http://www.shigen.nig.ac.jp/fly/nigfly/) will facilitate the application of dsRNA for 
large-scale functional genomics in the organism. 
 
5. - Gene targeting 
 
Phenotypic screening of random mutations or dsRNA is very powerful for implicating 
genes in processes where their involvement was not suspected.  In general, the 
association of mutations to genes requires a considerable investment of time and effort, 
with standard procedures involving complementation analysis to chromosomal 
deficiencies, mapping by meiotic recombination to visible markers, and, more recently, 
to single-nucleotide polymorphisms (226, 227).  In other cases, the workflow progress 
from a gene of interest to the generation of mutants, using reverse genetic techniques 
(228).  In those cases where the gene is targeted by a P element, the more frequent way 
to generate loss of function alleles are imprecise excision of the P-element and male 
recombination (229, 230).  In both cases, the end results are deletions of DNA flanking 
the P-element insertion site.  Additionally, when the P-element carries UAS sequences 
capable of directing the expression of the gene in presence of Gal4, an easy manner to 
recover loss-of-function alleles is searching for revertants of the miss-expression 
phenotype in a conventional chemical mutagenesis experiment (EMS or ENU) (231).  
The generation of large sets of strains carrying modified transposable elements 
containing FLP recombinase target sites (FRT; Fig. 1) has promoted the generation of 
small and molecularly mapped deficiencies by recombination between adjacent P 
elements or PiggyBac elements (47, 116).  Thus, because the P or PiggyBac element 
insertion sites are mapped to the sequence, the extent of the deficiency is predetermined 
and restricted to the DNA comprised between the two P or PiggyBac elements used (47, 
116).   
 
Other techniques based exclusively on sequence information intended to 
generate mutants in genes of interest are homologous recombination and tilling 
mutagenesis.  Homologous recombination consists in the insertion of linear DNA 
molecules within the corresponding chromosomal region through recombination of 
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paired sequences.  The main advantage is that specific changes can be engineered to 
modify the structure of the target gene, eliminating coding regions, introducing 
particular base changes that cause amino acid substitutions, or targeting a GFP molecule 
in frame to study subcellular localization.  The donor DNA linear molecule contains an 
I-SceI endonuclease recognition site, and it is cloned into a P-element flanked by FRT 
sites (45).  In transgenic flies containing this P-element and a source of FLP site-
specific recombinase and I-SceI, the expression of FLP and I-SceI excises the donor 
sequence from its chromosomal location and generates a double-strand break within the 
sequence that is homologous to the target gene, permitting homologous recombination 
between the donor and the corresponding chromosomal target locus (45).  This 
technique, however, is not applicable on a genomic scale, and it is also time-consuming 
and technically demanding.  Tilling mutagenesis is based on the large-scale detection of 
point mutations by Cel-I-mediated heteroduplex cleavage (232).  This approach allows 
screening a large collection of newly induced mutants for DNA alterations in a 
particular gene of interest (232).  Alternatively, PCR fragment-length polymorphisms 
coupled to mutagens inducing small deficiencies, such as hexamethylphosphoramide, 
has been applied as a reverse genetic technique for efficient mutation-detection (233).  
Because in both cases the identification of mutants relies exclusively in their molecular 
mapping to a region of interest, the experiments do not require any previous knowledge 
of the consequences of the inactivation of a gene. 
 
CONCLUSION 
 
Drosophila genes are conserved and present in a single copy in the genome, making this 
organism a very useful model in establishing the functions of mammalian orthologs.  
The described techniques, coupled to genome-wide efforts to generate interference 
RNA, P-UAS, P-Gal4, gene trap, chromosomal deficiencies and gene disruption lines, 
in combination to EST projects, global spatial-temporal expression analyses by RNA in-
situ hybridization and large-scale protein interaction maps using the Yeast-2-Hybrid 
system (234), are making possible to address a wide range of biological questions in the 
Drosophila model.  The task of global functional annotation is also greatly facilitated by 
the diverse initiatives to organize, curate and make available to the research community 
the immense amount of information related to the functional analysis of gene functions.   
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